Howe & Rusling’s Patterson-UTI PTEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-71
Closed 880
2020
Q1
$0 Sell
71
-7
-9% -$45 ﹤0.01% 857
2019
Q4
$1K Hold
78
﹤0.01% 775
2019
Q3
$1K Hold
78
﹤0.01% 786
2019
Q2
$1K Sell
78
-1
-1% -$13 ﹤0.01% 764
2019
Q1
$1K Sell
79
-2
-2% -$26 ﹤0.01% 763
2018
Q4
$1K Buy
81
+21
+35% +$310 ﹤0.01% 763
2018
Q3
$1K Hold
60
﹤0.01% 810
2018
Q2
$1K Hold
60
﹤0.01% 766
2018
Q1
$1K Sell
60
-10
-14% -$209 ﹤0.01% 873
2017
Q4
$2K Hold
70
﹤0.01% 727
2017
Q3
$1K Hold
70
﹤0.01% 839
2017
Q2
$1K Hold
70
﹤0.01% 902
2017
Q1
$2K Sell
70
-10
-13% -$270 ﹤0.01% 859
2016
Q4
$2K Hold
80
﹤0.01% 881
2016
Q3
$2K Buy
+80
New +$1.61K ﹤0.01% 878

Other funds holding PTEN

Howe & Rusling's PTEN Position: Q2 2020 in Review

Howe & Rusling sold out of Patterson-UTI (PTEN) in Q2 2020, closing a stake of 71 shares.

Howe & Rusling first reported a position in PTEN in Q3 2016 and held it in 15 quarters. The position peaked at $2K in Q4 2017. 233 funds tracked by Wall St. Rank hold PTEN as of Q2 2020.

  • Howe & Rusling reported no remaining Patterson-UTI position as of Q2 2020 after selling out during the quarter.
  • Howe & Rusling sold 71 Patterson-UTI shares in Q2 2020.
  • Howe & Rusling first reported a position in Patterson-UTI in Q3 2016 and held it in 15 quarters.
  • Howe & Rusling's Patterson-UTI position peaked at $2K in Q4 2017.
  • 233 funds tracked by Wall St. Rank held Patterson-UTI as of Q2 2020.

Based on Howe & Rusling's 13F filing for Q2 2020, filed 15 Jul 2020.